Compare S&P Global Inc (SPGI) vs Zoetis Inc (ZTS) Price & Performance

S&P Global IncTrade

Zoetis IncTrade

Price performance (Past 24H)

Key statistics

S&P Global Inc vs Zoetis Inc — how do they compare? S&P Global Inc trades at $431.27 (market cap $132.71B), while Zoetis Inc trades at $76.07 (market cap $31.95B). The key difference: S&P Global Inc is far larger — about 4.2× Zoetis Inc's market cap, and Zoetis Inc pays the higher dividend (2.78%). Which is the better fit depends on your goals.

	SPGI	ZTS
Market Cap	$132.71B	$31.95B
Sector	Financials	Health
52-Week High	$534.79	$156.76
52-Week Low	$370.42	$71.91
Enterprise Value	$144.68B	$39.24B
Dividend Yield	0.87%	2.78%

View details →View details →

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

SPGI

S&P Dow Jones and Pantera launch a new digital asset index focused on quality and real utility.PRNewsWire · 8 hours agoBullish S&P Global launches AI Data Portal with dual data retrieval methods for flexible AI access.PRNewsWire · 10 hours agoBullish S&P DJI and MSCI launch consultation on potential updates to GICS industry classification system.PRNewsWire · 4 days agoNeutral View details →

ZTS

Class action lawsuits filed against CALX, AVAV, ZTS, and LCID over alleged misleading statements.GlobeNewsWire · 4 days agoBearish View details →

About S&P Global Inc

S&P Global provides data and benchmarks to capital and commodity market participants. In 2021 and excluding IHS Markit, S&P Ratings was over 45% of the firm's revenue and over 55% of the firm's operating income. S&P Ratings is the largest credit rating agency in the world. The firm's other segments include Market Intelligence, Indices, and Platts. Market Intelligence provides desktop tools and other data solutions to investment banks, corporations, and other entities. Indices provides benchmarks for financial markets and is monetized through subscriptions, asset-based fees, and transaction-based royalties. Platts provides benchmarks to commodity markets, principally petroleum.

About Zoetis Inc

Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns slightly less than half of total revenue from production animals (cattle, pigs, poultry, and so on), and more than half from companion animal (dogs, horses, cats) products make up the other half. Its U.S. business is heavily skewed toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.